Related by context. All words. (Click for frequent words.) 58 Geoff Porges 57 Funtleyder 57 Trevor Polischuk 56 Jon LeCroy 55 analyst Jim Birchenough 55 Jami Rubin 55 analyst Gbola Amusa 54 Joel Sendek 54 Dr. Jim Birchenough 54 Bruce Cranna 53 analyst Geoffrey Porges 53 analyst Cory Kasimov 53 Chris Shibutani 53 Annabel Samimy 53 Gbola Amusa 53 analyst Geoffrey Meacham 53 Howard Tubin 53 Kemp Dolliver 53 Leerink Swan 53 analyst Yaron Werber 52 JoAnne Feeney 52 analyst Glenn Novarro 52 Jason Kolbert 52 Jon Lecroy 52 Susan Donofrio 52 Jason Kantor 52 Cory Kasimov 52 Michael Krensavage 51 analyst Jonathan Aschoff 51 Larry Biegelsen 51 Mike Krensavage 51 Krensavage 51 Matthew Borsch 51 analyst Bruce Cranna 51 analyst Randall Stanicky 51 Yaron Werber 51 Geoff Meacham 50 Karl Heinz Scheunemann 50 analyst Liana Moussatos 50 Geoffrey Porges 50 Natexis Bleichroeder 50 Mark Monane 50 Grofik 50 Gary Nachman 50 Eric Ende 50 Leerink 50 Carl Seiden 50 analyst Sapna Srivastava 50 analyst George Grofik 50 analyst Anthony Chukumba 50 McAlpine Associates 50 Herman Saftlas 50 Steven Harr 50 Lawrence Biegelsen 50 Ulrich Huwald 50 Bret Holley 50 George Grofik 50 analyst Lawrence Keusch 49 analyst Jami Rubin 49 Navid Malik 49 Suji De Silva 49 Geoffrey Meacham 49 Gerard Klauer Mattison 49 analyst Ghansham Panjabi 49 Jim Reddoch 49 Fulcrum Global Partners 49 analyst Steven Wieczynski 49 Jason Gurda 49 analyst Jim Reddoch 49 Andrew Goodsall 49 Ronny Gal 49 Andreas Theisen 49 analyst Joanne Wuensch 48 Zocor Zetia 48 Roopesh Patel 48 Bert Hazlett 48 Glenn Novarro 48 Hamed Khorsand 48 analyst Seamus Fernandez 48 Mark Schoenebaum 48 analyst Charles Boorady 48 Seamus Fernandez 48 Eric Beder 48 Duane Grubert 48 analyst Bruce Nudell 47 analyst Amit Hazan 47 Jeffrey Frelick 47 analyst Robert Campagnino 47 Karl Heinz Koch 47 analyst Alex Gauna 47 reaffirmed Outperform rating 47 Rachael Rothman 47 WBB Securities 47 Eric Coldwell 47 Suntrust Robinson Humphrey 47 analyst Jeff Fidacaro 47 WBB Securities LLC 47 analyst Larry Biegelsen 47 Ian Somaiya 46 analyst Mark Schoenebaum 46 Rommel Dionisio 46 analyst Vijay Jayant 46 Quynh Pham 46 Kenji Masuzoe 46 analyst Robert Cihra 46 Mark Bronzo managing 46 analyst Rommel Dionisio 46 analyst Emme Kozloff 46 Darren Lehrich 46 Jerry Doctrow 46 Coffina 46 Scott Mushkin 46 FTN Midwest 46 Jan Wald 46 Damien Conover 46 Edwin Hemwall 46 Oppenheimer OPY 46 Keay Nakae 46 Punk Ziegel 46 Raj Denhoy 46 analyst Michael Exstein 45 Douglas Harned 45 Douglas Sipkin 45 analyst Frank Mitsch 45 Drbul 45 Shenyin Wanguo Securities 45 analyst Victor Bareno 45 Bristol Myers BMY 45 Jeff Wlodarczak 45 Rajesh Ghai 45 Natixis Bleichroeder analyst 45 Dr. Joshua Schimmer 45 Brian Bapty 45 Dhulsini de Zoysa 45 Andrew Kligerman 45 James Kumpel 45 McKesson MCK 45 Piper Jaffray PJC 45 Paul Horrmann broker 45 Deutsche Ixe 45 Jeff Van Sinderen 45 Daniel Berenbaum 45 Lawrence Keusch 45 Philip Alling 45 Satya Chillara 45 Delafield Hambrecht 45 Vioxx Zocor 45 JB Hanauer & 45 analyst Shebly Seyrafi 45 SG Cowen 45 Tenthoff 45 analyst Silke Stegemann 45 Merck MRK Pfizer PFE 45 Muken 44 Akhtar Samad 44 BernsteinResearch 44 analyst Jason Brueschke 44 Taunya Sell 44 Sinopac Securities 44 MRK.N 44 Charlie Di Bona 44 Clark Orsky 44 analyst William Pecoriello 44 SGP.N Quote Profile Research 44 analyst Douglas Sipkin 44 Merck boceprevir 44 Goozner 44 Adam Klauber 44 generic Copaxone 44 Leerink Swann 44 Drew Matus economist 44 Prudential Equity 44 analyst Tore Svanberg 44 analyst Eric Bosshard 44 Steven Winoker 44 Bruce Nudell 44 Tao Levy 44 Qian Qimin strategist 44 reaffirmed Market Perform 44 Biren Amin 44 Ananda Baruah 44 Birinyi Associates Inc 44 analyst Satya Chillara 44 Lauri Brunner 44 IG HCR ;) CO 44 Benny Lorenzo 44 John DiFucci 44 Creditsights 44 William Pecoriello 44 Scott Geels 44 Abbott ABT 44 BWS Financial 44 analyst Christopher Svezia 44 analyst Jason Gurda 44 ConsumerEdge Research 43 Stanicky 43 Sanjiu Medical 43 Miller Tabek 43 Stacy Rasgon 43 Deane Dray 43 Marla Backer 43 Co. MRK.N 43 analyst Junaid Husain 43 analyst Mark Swartzberg 43 analyst Sheryl Skolnick 43 Randal Konik 43 analyst Hunter Keay 43 Schering Plough NYSE SGP 43 analyst Gregory Melich 43 analyst Elizabeth Osur 43 Auriga USA 43 strategist Tony Crescenzi 43 Jeffrey Holford 43 analyst Timothy Conder 43 David Turkaly 43 Stacey Widlitz analyst 43 Guotai Jun'an Securities 43 Singulair asthma 43 Charles Cerankosky 43 Robert Cihra 43 Gimme Credit Publications 43 Inc WPI.N 43 Avik Roy 43 Nils Lesser 43 Natixis Bleichroeder 43 Denhoy 43 Todd Bault 43 Ken Cacciatore 43 Cochran Caronia 43 ANALYST TAKE Stifel Nicolaus 43 UBS analyst Gbola 43 reaffirmed Neutral 43 Sterling Auty 43 Kazaka Securities 43 analyst Jeffrey Zekauskas 43 analyst Maarten Altena 43 Kalpesh Kapadia 43 Steve Brozak 43 Les Funtleyder 43 Maxcor Financial 43 Kepler Equities 43 Stifel Nicholas 43 Brusuelas Analytics 43 Analyst Les Funtleyder 43 analyst Rebecca Runkle 43 Noven Pharmaceuticals NOVN 42 Derrick Dagnan 42 Luuk van Beek 42 CRT Capital 42 SG Cowen Securities 42 analyst Randal Konik 42 Kepler Equities analyst 42 Leerink Swann analyst 42 Ehrenkrantz King Nussbaum 42 Merck nyse MRK 42 analyst Hemant Shah 42 PiperJaffray analyst 42 Anthony Polini 42 Jeremy Sussman 42 Rob Cihra 42 analyst Dara Mohsenian 42 Quadrani 42 Moshe Orenbuch 42 analyst Maged Shenouda 42 NYSE SGP 42 Co. nyse LLY 42 UOB KayHian 42 Co. NYSE MRK 42 Jefferies NYSE JEF 42 Feinseth 42 Brozak 42 Tony Clapsis 42 analyst Eric Beder 42 Hans Mosesmann 42 Michael Bruynesteyn 42 analyst Edward Yruma 42 Pecoriello 42 analyst Bijan Moazami 42 Jay Gelb 42 strategist Brian Belski 42 Betsy Van Hees 42 Carret & 42 analyst Deane Dray 42 Jefferies JEF 42 analyst Les Funtleyder 42 Deborah Weinswig 42 Saftlas 42 Timothy Conder 42 Alexia Quadrani 42 Geoff Ruddell 42 Steven Wieczynski 42 Bookvar 42 April Scee 42 Zyprexa Cymbalta 42 Carsten Kunold 42 analyst Joshua Shanker 42 analyst Elemer Piros 42 Joseph Agnese 42 Michael Masdea 42 Li Maoyu 42 analyst Robert Drbul 42 Nicholas Aberle 42 OTC Claritin 42 Joe Osha 42 JB Hanauer 41 Jennifer Fritzsche 41 Steven Brozak 41 analyst Ashwin Shirvaikar 41 FTN Equity Capital Markets 41 Nigel Dally 41 analyst Matthew Borsch 41 Merck Finck analyst 41 Pacific Growth Equities 41 SW Bach 41 Joshua Shanker 41 Tang Xiaosheng 41 analyst Constance Maneaty 41 analyst Nicholas Heymann 41 spokeswoman Mariann Caprino 41 Robert Campagnino 41 OTC Mevacor 41 strategist Peter Boockvar 41 Adrienne Tennant 41 floor brokerage Mogavero 41 FTN Equity 41 Robert Lacoursiere 41 Drugmakers Merck & 41 analyst Srini Pajjuri 41 ANALYST TAKE JP Morgan 41 Moshe Katri 41 Nollenberger Capital 41 Srini Pajjuri 41 ANALYST TAKE Analysts 41 analyst Katherine Styponias 41 Steven Wieting 41 FTN Midwest Securities 41 Cannacord Genuity 41 Lawrence Klatzkin 41 Ghriskey 41 analyst Kirk Materne 41 analyst Margaret Mager 41 SNS Securities 41 analyst Ali Dibadj 41 ThinkEquity LLC 41 Justin Hott 41 Jesse Tortora 41 Lauren Cooks Levitan 41 nyse SGP news 41 analyst Mark Wiltamuth 41 Jason Napodano 41 analyst Colby Synesael 41 P. Heymann 41 Alain Karaoglan 41 analyst Kimberly Greenberger 41 Robin Diedrich 41 analyst Gurinder Kalra 41 Daljeet Kohli head 41 Esther Kwon 41 spokeswoman Rosemarie Yancosek 41 analyst Jeffrey Fidacaro 41 Louis Miscioscia 41 NASDAQ SCRX specialty 41 Virginia Genereux 41 analyst Stephen Tusa 41 analyst Arvind Bhatia 41 Donald Fandetti 41 AstraZeneca AZN.L 行情 41 Piper Jaffray reiterate 41 Tore Svanberg 41 Michael Vinciquerra 41 Andrew Speller 41 Robert Drbul 41 analyst Michael Bruynesteyn 41 analyst Budd Bugatch 41 analyst Koya Tabata 41 analyst Brad Hintz 41 Silversteyn 41 John Janedis 41 Meredith Adler 40 analyst Ajit Pai 40 analyst Albert Savastano 40 Edwin Groshans 40 economist Tushar Poddar 40 Mito Securities 40 analyst Charles Grom 40 analyst Alexia Quadrani 40 Alan Skrainka chief 40 Brean Murray 40 Underweight rating 40 Steve Massocca 40 Dan Ortwerth 40 orthopedic implant maker 40 analyst Navid Malik 40 Isaac Ro 40 ThinkEquity downgraded 40 WR Hambrecht reiterate 40 Ixis Securities 40 analyst Stacey Widlitz 40 Erik Suppiger 40 analyst Dan Wantrobski 40 Joseph Pantginis 40 Stephan Kalb 40 Matrix Asset 40 Neutral Weight 40 analyst Matthew DiFrisco 40 Ana Gupte 40 Ira Loss 40 Sanford C. Bernstein 40 analyst Kristine Koerber 40 Co LLY.N 40 Maynard Um 40 analyst Walter Piecyk 40 Wang Junqing 40 Chua Hak Bin 40 Schwab Soundview Capital Markets 40 Utendahl Capital Partners 40 Brad Reback 40 Roche Mircera 40 ICEA Securities 40 maker Barr Pharmaceuticals 40 Hulk Caris & 40 WR Hambrecht 40 Tee Sze Chiah 40 Barton Crockett 40 Helvea SA 40 Peter Nesvold 40 RW Baird analyst 40 DBS Vickers Securities 40 analyst Damien Conover 40 Mark Schappel 40 Cantor Fitzgerald reiterates 40 Michael Derchin 40 Petercam analyst 40 Tang Yonggang 40 Charles Minervino 40 ViroPharma Nasdaq VPHM 40 Maneaty 40 analyst Mehdi Hosseini 40 Mercks 40 drug anacetrapib 40 Matthew DiFrisco 40 analyst Christa Quarles 40 Mark Astrachan 40 Mark Bacurin 40 Sumit Dhanda 40 C. Bernstein 40 Zuercher Kantonalbank analyst 40 analyst Tony Wible 40 Claudia Shank Hueston 40 Guosen Securities 40 Capstone Investments 40 Brion Tanous 40 Matt Nemer 40 Neely Tamminga 40 Zocor Merck 40 Miller Tabak 40 Susquehanna Financial 40 Arnie Ursaner 40 Tobias Levkovich Citigroup 40 Edward Najarian 40 Stuart Plesser 40 Emme Kozloff 40 ANALYST TAKE Goldman Sachs 39 analyst Michael Masdea 39 Douglas Anmuth 39 Jeremy Batstone 39 analyst Joseph Greff 39 Stephen Tusa 39 analyst Lawrence Klatzkin 39 Tony Ursillo 39 WBB Securities analyst 39 anlayst 39 Doreen Mogavero president 39 analyst Anna Torma 39 Avondale Partners 39 Gregory Drahuschak 39 analyst Mark Edelstone 39 Tad Piper 39 Dan Greenhaus 39 analyst Bill Pecoriello 39 Exane BNP 39 Bill Pecoriello 39 David Bleustein 39 Fulcrum Global 39 analyst Gregory Badishkanian 39 John Kartsonas 39 analyst Kemp Dolliver 39 Raymond Neidl 39 Analyst Ray Neidl 39 Generic drugmakers 39 Brian Rayle 39 Meredith Whitney Advisory 39 Jeff Fidacaro 39 analyst Vivek Arya 39 Jeffrey Blaeser 39 Maintains Neutral 39 analyst Laurent Horrut 39 analyst Uche Orji 39 analyst Hans Mosesmann 39 Helfstein 39 Adrianne Shapira 39 analyst Laura Champine 39 Nik Modi 39 Colin McGranahan 39 Yumi Nishimura deputy 39 midstage clinical testing 39 Kartik Mehta 39 Leonard Teitelbaum 39 Walter Piecyk 39 Everbright Futures 39 SoundView Technology 39 Vishal Shreedhar 39 pharmacuetical 39 analyst 39 Cleveland Rueckert 39 Oddo Securities 39 analyst Betsy Graseck 39 William F. Tanona 39 Martilotti 39 Richard Fetyko 39 Merck NYSE MRK 39 FTN Midwest Research 39 Brent Thill 39 Cai von Rumohr 39 Richard Bilotti 39 Douglas Peta 39 Konrad Becker 39 HwangDBS Vickers 39 Dr. Gail Cawkwell 39 analyst Adrianne Shapira 39 Scott Krasik 39 Sara Michelmore 39 Dahlman Rose downgraded 39 Zhejiang Tianyuan Bio 39 Procrit anemia drug 39 analyst Kevin Crissey 39 Grasher 39 Drew Matus 39 Broadpoint Amtech 39 Teva Ivax 39 Friedman Billings Ramsay 39 Advest 39 Christopher Danely 39 Broadpoint AmTech 39 NASDAQ SOMX specialty 39 Vijay Rakesh 39 FBR Capital Markets FBCM 39 Harris Nesbitt 39 Jonathan Golub 39 analyst Jesse Tortora 39 Gregg Moskowitz 39 Edwin Mok 39 Jeetil Patel 39 Reiterates Hold 39 Generic drugmaker 39 Nabi Biopharmaceuticals NABI 39 Equal Weight rating 39 ANALYST TAKE Bear Stearns 39 Budd Bugatch 39 Piper Jaffray nyse PJC 39 Lazard Capital 39 analyst Ehud Gelblum 39 Equinet analyst 39 Philip Cusick 38 analyst Mark Wienkes 38 Stephen Dashevsky 38 Brett Hoselton 38 Debon Securities 38 Dr. LaMattina 38 Tony Crescenzi strategist 38 Reiterates Neutral Rating 38 looming patent expiries 38 Richard Kugele 38 Thomas Cholnoky 38 Todd Duvick 38 Steve Shubitz 38 Peter Mirsky 38 Squibb Co. 38 MERIZ 38 Badishkanian 38 Ray Neidl 38 Crestor cholesterol lowering 38 Barrie Cornes 38 analyst Bruce Harting 38 Joseph Amaturo 38 analyst Inder Singh 38 Analyst Steve Brozak 38 Peter Arment 38 Schwab Soundview 38 Piper Jaffrey 38 analyst Lizabeth Dunn 38 Bank Degroof 38 David Hochstim 38 Brian Youngberg 38 ThinkEquity Partners 38 Bhavin Shah 38 Camilo Lyon 38 Vertex telaprevir 38 analyst Eileen Furukawa 38 GlaxoSmithKline PLC GSK.LN 38 analyst William Tanona 38 Crowell Weedon & 38 Kabu.com Securities 38 Zyprexa schizophrenia 38 BernsteinResearch analyst 38 analyst Peter Ruschmeier 38 Cozaar Hyzaar 38 Vijay Jayant 38 strategist Teun Draaisma 38 William Tanona 38 Craig Siegenthaler 38 Brigantine Advisors analyst 38 analyst Robert Koort 38 analyst Andrey Glukhov 38 brokerage Mogavero Lee 38 Landsbanki Kepler 38 Steve Neimeth portfolio 38 UBS Warburg 38 analyst Dinesh Moorjani 38 Jeff Omohundro 38 Sandoz GmbH 38 Steven Kron 38 Nathan Schneiderman 38 analyst Allan Mishan 38 ANALYST TAKE Lehman Brothers 38 analyst Kian Abouhossein 38 Campagnino 38 Ragen Mackenzie 38 Pfizers 38 Shire LSE SHP 38 strategist Bruce Bittles 38 Michael Rehaut 38 Tradition Asiel Securities 38 Ladenburg Thalmann analyst 38 Helane Becker 38 Kathryn Huberty 38 Nicholas Heymann 38 Freidman Billings Ramsey 38 Oscar Gruss & 38 Keybanc Capital Markets 38 Janney Montgomery Scott 38 Tsuyoshi Nomaguchi strategist 38 Stifel Nicolas 38 Sackner Bernstein 38 CE Unterberg 38 analyst Kenneth Usdin 38 ANALYST TAKE Credit Suisse 38 Edgar Roesch 38 analyst Ton Gietman 38 Novartis Diagnostics 38 B. Nemeroff 38 Perrigo PRGO 38 Co. LLY.N 38 GlaxoSmithKline Plc Novartis AG 38 analyst Mark Lipacis 38 Abbott Niaspan 38 BRL.N Quote Profile Research 38 Punk Ziegel & 38 Craig Kennison 38 ANALYST TAKE Jefferies 38 Steven Ricchiuto chief 38 Dlouhy Merchant 38 ThinkPanmure 38 analyst Safa Rashtchy 38 Zyrtec allergy 38 Arnold Ursaner 38 Oscar Gruss 38 ThinkEquity Partners LLC 38 Sector Outperformer 38 ThinkEquity analyst 38 analyst Youssef Squali 38 James Janesky 38 Mark Kalinowski 38 Scott Snyder XPRESSTRADE 38 Nikos Theodosopoulos 38 Ragen MacKenzie 38 J. Fassler 38 Fox Pitt Kelton 38 Ramon Llamas IDC 38 Leckow 38 Ricky Goldwasser 37 analyst Aldo Mazzaferro 37 Doreen Mogavero 37 Ozan Akcin chief 37 Morgan Stanley MUFG 37 analyst Pablo Zuanic 37 Bugatch 37 analyst Alexander Peterc 37 Scot Ciccarelli 37 Jeffrey Kleintop 37 Staphos 37 Carl Christensen XPRESSTRADE 37 Portales Partners 37 analyst Rob Campagnino 37 analyst Laura Conigliaro 37 Todd Rethemeier 37 Sam Poser 37 Carla Antunes da Silva 37 Matt DiFrisco 37 Lazard Capital Markets 37 GimmeCredit 37 analyst Lori Appelbaum 37 analyst Alan Bezoza 37 analyst Joseph Altobello 37 Mylan Nasdaq MYL 37 analyst Dean Gianoukos 37 analyst Steve Brozak 37 BAS ML 37 economist Zach Pandl 37 David Begleiter 37 analyst Aaron Rakers 37 Drugmaker Merck & 37 Stifel Nicholaus 37 Nexium Prilosec 37 analyst Katy Huberty 37 Kellner DiLeo Cohen 37 strategist Makoto Yamashita 37 analyst Julio Quinteros 37 FTN Equity Capital 37 Kaufman Bros 37 Pierpont Securities 37 Analyst Dick Bove 37 Feltl & 37 Sterne Agee analyst 37 unmetabolized medicine 37 analyst Donald Fandetti 37 John Herrlin 37 Kaufman Brothers 37 Bruce Harting 37 Jochen Rothenbacher 37 Klaskow 37 Kash Rangan 37 Craig Woolford 37 Co MRK 37 P. Klinefelter 37 Humira arthritis 37 Analyst Cai von 37 Amy Noblin 37 ThinkEquity upgraded 37 Kruszenski 37 Peter Appert 37 Calyon Securities USA 37 Rabo Securities 37 Dennis Forst 37 analyst Glenn Schorr 37 analyst Justin Yagerman 37 analyst Curtis Shauger 37 Dorothy Lakner 37 analyst Cai von 37 Sanford Bernstein analyst 37 Alton Stump 37 Cathy Seifert 37 economist Richard Yamarone 37 Vertex hepatitis C 37 Youssef Squali 37 Piper Jaffray downgraded 37 analyst Richard Fetyko 37 Bergenstal 37 Kenneth Zaslow 37 Eric Bosshard 37 Brean Murray Carret 37 antidepressant Remeron 37 FW Holst 37 JP Morgan 37 analyst Ajay Jain 37 Stiffel Nicolaus 37 analyst Heather Bellini 37 Bryan Garnier 37 Hapoalim Securities 37 Huang Xiangbin 37 Brian Gesuale 37 Carlos Laboy 37 analyst Yair Reiner 37 Lewent 37 Meiwa Securities 37 Wachovia Securities 37 Peter Jankovskis 37 Yusuke Sakai manager 37 Justin Sebastiano 37 Tobias Levkovich 37 analyst Christopher Growe 37 Norinchukin Zenkyoren Asset Management 37 Tahira Afzal 37 ANALYST TAKE Merrill Lynch 37 TownHall Investment 37 Zuanic 37 analyst Kurt Hallead 37 analyst Sasa Zorovic 37 Wedbush Morgan analyst 37 Mark Swartzberg 37 Tanona 37 economist Drew Matus 37 BGB Securities 37 Tom Gidley Kitchin 37 Cary Leahey economist 37 Sanford Bernstein 37 Drugmaker Bristol Myers Squibb 37 Christopher Horvers 37 Bank Vontobel 37 Sterne Agree 37 Rudy Narvas senior 37 Farooq Hanif 37 Peter Dunay investment 37 WestLB Panmure 37 Meiji Dresdner Asset Management 37 Joseph Nadol 37 strategist Abhijit Chakrabortti 37 INVEGA ™ 37 Montevirgen 37 Telsey Advisory Group 37 Calyon Securities 37 CJS Securities 36 Co BDX 36 Guy Moszkowski 36 GlaxoSmithKline PLC Novartis AG 36 analyst Aryeh Bourkoff 36 Janney Montgomery 36 Saul Ludwig 36 Wedbush analyst 36 Squibb Eli Lilly 36 Geneva broker Helvea 36 Westhall Capital 36 Zekauskas 36 HOSPIRA 36 analyst Aram Rubinson 36 analyst Farha Aslam 36 Boockvar 36 analyst Jon Bergtheil 36 Nagayuki Yamagishi strategist 36 Strauzer 36 analyst Benjamin Reitzes 36 John Segrich 36 firm Gimme Credit 36 Landesbank Rheinland Pfalz 36 Hiroyuki Fukunaga chief 36 Bill Kreher 36 Glenn Schorr 36 Ursaner 36 hypertension drugs Cozaar 36 Sipkin 36 Mitsubishi UFJ Asset Management 36 Andy Miedler 36 Laszlo Birinyi 36 AMBAC Financial 36 Arnie Berman 36 Thrivent Large Cap 36 Pali Capital 36 IDFC SSKI Securities 36 analyst Benjamin Swinburne 36 Thomas R. Wadewitz 36 CreditSights analyst 36 Kartsonas 36 Caylon Securities 36 Schwab SoundView 36 Gajrawala 36 Chief Executive Jeffrey Kindler 36 Loomis Sayles & 36 analyst Frederick Searby 36 Mark Wienkes 36 Ladenburg Thalman 36 Ajay Rajadhyaksha 36 di Galoma 36 Laura Conigliaro 36 CE Unterberg Towbin 36 looming patent expirations 36 Ed Atorino 36 analyst Dan Wewer 36 analyst Gene Munster 36 Richard X. Bove 36 Kirk Materne 36 Pfizer Wyeth 36 Equinet 36 Kuni Chen 36 Punk Ziegel analyst 36 analyst Edwin Mok 36 Patrick Chidley 36 Jayson Noland 36 Risperdal schizophrenia drug 36 Novartis Gilenia 36 Ardour Capital 36 Vanlev 36 analyst Alain Karaoglan 36 Ichiyoshi Securities 36 Styponias 36 uh ruh 36 analyst Doug Anmuth 36 Mark Warnsman 36 Merrill Lynch OOTC MERIZ 36 economists Takuji Okubo 36 Barclays Maintains 36 heads ConsumerEdge Research 36 analyst Deborah Weinswig 36 Marianne Wolk 36 UCB Keppra 36 Casesa Shapiro Group 36 Dudack Research Group 36 Citi Investment 36 Overweight rating 36 analyst Tal Liani 36 Merck 36 Daniel Fannon 36 Moszkowski wrote 36 Credit Sights 36 SoundView Technology Group 36 Matthew Heimermann 36 Cialis Cymbalta 36 Drew Brosseau 36 Langen McAlenney 36 Joseph C. Amaturo 36 Laura Champine 36 Tom Cholnoky 36 Bolton Weiser 36 Northcoast Research 36 infusible 36 JGB strategist 36 George Pipas Ford Motor 36 Lipacis 36 Lehman Bros. 36 Anurag Rana 36 Elliot Spar market 36 blockbuster Plavix 36 GARP Research 36 Daniel Renouard 36 WHITEHOUSE STATION NJ Drugmaker 36 Underperform rating 36 analyst Jeffrey Klinefelter 36 Shelly Lombard senior 36 Kathy Styponias 36 analyst Brent Thill 35 analyst Greg Mesniaeff 35 spokeswoman Lenore Gelb 35 Heather Bellini 35 Jeffery Harte 35 Troy Mastin 35 Michael Taiano 35 deposition Topol 35 Marketfield Asset Management 35 firm CreditSights 35 Elara Securities 35 Maintains Overweight 35 Retail Forecasting 35 drugmakers 35 Claritin allergy 35 analyst PJ Juvekar 35 Sanganeria 35 Piper Jaffray 35 Enbrel arthritis 35 Betsy Graseck 35 Rod Bourgeois 35 Analyst Gene Munster 35 Savner 35 BMO Capital 35 FBR Capital NASDAQ FBCM 35 JMP Securities downgraded 35 Katherine Egbert 35 analyst Christopher Danely 35 anticholesterol 35 Dickie Irvin 35 Bill Shope 35 Anmuth 35 Casesa 35 Rudy Narvas 35 R. Miscioscia 35 Peter Misek 35 Wrightson ICAP 35 Paul Sagawa 35 Marusan Securities 35 analyst Shaul Eyal 35 Erkki Vesola 35 Rating Maintained 35 analyst Ann Duignan 35 Himanshu Patel 35 Eli Lilly Prozac 35 Rick Sherlund 35 Cochran Caronia Waller 35 Credit Suisse First 35 Batlivala & 35 ANALYST TAKE JPMorgan 35 Patrick Walravens 35 blockbuster antidepressant Effexor 35 Christopher Svezia 35 HC Wainwright 35 Ronald Tadross 35 McQueen Ball 35 Petercam Securities 35 analyst Louis Miscioscia 35 Wedbush 35 George Staphos 35 Mark Lipacis 35 Broadpoint Amtech analyst 35 Versant Partners analyst 35 Neutral rating 35 Metehan Sen 35 Eric Martinuzzi 35 Ken Hoexter 35 Jonathan Ruykhaver 35 Jason Avilio 35 Rebecca Runkle 35 Chad Morganlander portfolio